GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,252.90
arrow_downward
-0.55%(-12.40) 1D
Oct 14, 9:26:55 AM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹2,275.00
High
₹2,286.40
Low
₹2,242.00
Mkt. cap
635.82B
Avg. vol.
576.02K
Volume
30.64K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.38
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,275.00
High
₹2,286.40
Low
₹2,242.00
Mkt. cap
635.82B
Avg. vol.
576.02K
Volume
30.64K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
35.38
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
Traders Union
·
51 minutes ago
Ryan Detrick: S&P 500 up about 18% since March 30 2026 after midterm year pattern
TradingView
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Mixed Amid Rising Oil Prices Ahead Of CPI Data: BAC, RIVN, SLS, GME Stocks In Focus
HDFC Sky
·
49 minutes ago
US Stocks End Mixed as Chip Selloff Hits Nasdaq
å·´å£«çš„å ±
·
2 hours ago
U.S. stocks end lower amid chip selloff
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd